Tag:
Wellcome Trust
Latest Headlines
Latest Headlines
Wellcome Trust gambles on biotech startups with new £200M fund
The U.K.'s largest charity has already begun to pour some serious pounds into biotech startups. The Wellcome Trust has organized its efforts under a new venture unit called Syncona to back early-stage outfits in biotech and other healthcare sectors with an initial £200 million ($325 million) fund.
Cell Medica lands $26.5M in venture cash to fuel U.S. expansion
London-based Cell Medica is coming to America. The cell therapy developer says it has pieced together a $26.5 million round to finance new operations in Texas to work on a cancer immunotherapy program.
Edmond de Rothschild scores $152M for its fourth biotech fund
Edmond de Rothschild Investment Partners, a high-profile venture player in the European life sciences scene, has braved a tough financial environment and rounded up a bit more than $152 million for its fourth biotech fund.
Biotech venture rounds dwindle in Europe, tracking U.S. trend
Fresh on the heels of the news of a disappointing quarter for biotech investing in the U.S., Dow Jones VentureSource has done the math for Europe and come up with an equally dispiriting set of stats.
U.K. officials ready $286M fund to fuel a biotech revival
U.K. officials are preparing for the imminent launch of a $286 million fund designed to revive the country's biotech industry.
Wellcome joins chorus calling for free online access to medical research
Wellcome Trust no longer wants to pay for medical research that ends up guarded behind a pay wall.
Billions in new venture cash targeted at early-stage biotech efforts
The analysts at Burrill & Co. took out their calculators and concluded that $2.6 billion in new venture funds for translation and early-stage work materialized in the U.S. and Europe in the last two months.
New $317M biotech fund takes off at Wellcome Trust
The U.K's wealthiest charity has blueprinted big plans to back fledgling therapeutics and diagnostics companies with a brand new £200 million ($317 million) fund.
Court ruling could derail ambitious stem cell program for synthetic blood
A team of university researchers in the U.K. are working on an efficient formula for creating mass stocks of synthetic blood from stem cells. And they say may be just a couple of years from beginning
After three centuries, quinine no longer best for malaria
The largest-ever clinical trial in patients suffering from severe malaria--funded by the Wellcome Trust and published in The Lancet--is recommending that a 300-year-old treatment for the disease that
